Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study.
Ming LiDavid M RoderKatina D'OniseDavid WaltersGelareh FarshidElizabeth BuckleyChris KarapetisRohit JoshiTimothy PriceAmanda TownsendCaroline Louise MillerDavid CurrowKate PowellDianne Buranyi-TrevartonIan OlverPublished in: BMJ open (2020)
Stage varied by age, diagnostic period and socioeconomic status, and was a stronger predictor of survival than other statistically significant sociodemographic predictors. Achieving earlier diagnosis outside the original BreastScreen target of 50-69 years (as applying <2014) and in residents of socioeconomically disadvantaged areas likely would increase cancer survival at a population level.